Pneumocystis Pneumonia

Global HIV/AIDS Medicine

Volumn , Issue , 2008, Pages 309-321

  Davis, J Lucian ^a   Huang, Laurence ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952295324     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2882-6.50033-2     Document Type: Chapter

References (40)

1. Serraino D, Puro V, Boumis E, et al. Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS: Europe, 1993-2000. Aids 2003, 17:2109-2116.
2. Morris A, Lundgren JD, Masor H, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004, 10:1713-1720.
3. Worodria W, Okot-Nwang M, Yoo SD, et al. Causes of lower respiratory infection in HIV-infected Ugandan adults who are sputum AFB smear-negative. Int J Tuberc Lung Dis 2003, 7:117-123.
4. Fisk DT, Meshnick S, Kazanjian PH Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis 2003, 36:70-78.
5. Kaplan JE, Masur H, Holmes KK Guidelines for preventing opportunistic infections among HIV-infected persons -2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002, 51:1-52.
6. Phair J, Munoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group N Engl J Med 1990, 322:161-165.
7. Stansell JD, Osmond DH, Charlebois E, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997, 155:60-66.
8. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984, 100:663-671.
9. Thomas CF, Limper AH Pneumocystis pneumonia. N Engl J Med 2004, 350:2487-2498.
10. Kales CP, Murren JR, Torres RA, et al. Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med 1987, 147:1413-1417.
11. Huang L, Stansell JD AIDS and the lung. Med Clin North Am 1996, 80:775-801.
12. Skelly M, Hoffman J, Fabbri M, et al. S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Lancet 2003, 361:1267-1268.
13. DeLorenzo LJ, Huang CT, Maguire GP, et al. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 1987, 91:323-327.
14. Huang L, Stansell J, Osmond D, et al. Performance of an algorithm to detect Pneumocystis carinii pneumonia in symptomatic HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Chest 1999, 115:1025-1032.
15. Datta D, Ali SA, Henken EM, et al. Pneumocystis carinii Pneumonia: The Time Course of Clinical and Radiographic Improvement. Chest 2003, 124:1820-1823.
16. Huang L, Hecht FM, Stansell JD, et al. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful?. Am J Respir Crit Care Med Jun 1995, 151:1866-1871.
17. Larsen HH, Huang L, Kovacs JA, et al. A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis 2004, 189:1679-1683.
18. Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004, 53:1-112.
19. Huang L, Crothers K, Atzori C, et al. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg Infect Dis 2004, 10:1721-1728.
20. Beard CB, Roux P, Nevez G, et al. Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004, 10:1729-1735.
21. Stein CR, Poole C, Kazanjian P, et al. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii Pneumonia. Emerg Infect Dis 2004, 10:1760-1765.
22. Crothers K, Beard CB, Turner J, et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. Aids 2005, 19:801-805.
23. Kazanjian PH, Fisk D, Armstrong W, et al. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China. J Infect Dis 2004, 189:1684-1687.
24. Zar HJ, Alvarez-Martinez MJ, Harrison A, et al. Prevalence of dihydropteroate synthase mutants in HIV-infected South African Children with Pneumocystis jiroveci Pneumonia. Clin Infect Dis 2004, 39:1047-1051.
25. Iliades P, Meshnick SR, Macreadie IG Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs. Antimicrob Agents Chemother 2005, 49:741-748.
26. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990, 323:1500-1504. The National Institutes of Health - University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia.
27. de Quiros JC, Bernaldo Lopez, Miro JM, Pena JM, et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98. N Engl J Med 2001, 344:159-167.
28. Ledergerber B, Mocroft A, Reiss P, et al. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight Eur Study Groups N Engl J Med 2001, 344:168-174.
29. Bishop LR, Kovacs JA Quantitation of anti-Pneumocystis jirovecii antibodies in healthy persons and immunocompromised patients. J Infect Dis 2003, 187:1844-1848.
30. Daly KR, Koch J, Levin L, et al. Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerg Infect Dis 2004, 10:848-854.
31. Respaldiza N, Medrano FJ, Medrano AC, et al. High seroprevalence of Pneumocystis infection in Spanish children. Clin Microbiol Infect 2004, 10:1029-1031.
32. Kovacs JA, Gill VJ, Meshnick S, et al. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 2001, 286:2450-2460.
33. An CL, Gigliotti F, Harmsen AG Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response. Infect Immun 2003, 71:2065-2070.
34. Gigliotti F, Harmsen AG, Wright TW Characterization of transmission of Pneumocystis carinii L sp. muris through immunocompetent BALB/c mice. Infect Immun 2003, 71:3852-3856.
35. Vestereng VH, Bishop LR, Hernandez B, et al. Quantitative real-time polymerase chain-reaction assay allows characterization of Pneumocystis infection in immunocompetent mice. J Infect Dis 2004, 189:1540-1544.
36. Maskell NA, Waine DJ, Lindley A, et al. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax 2003, 58:594-597.
37. Morris A, Kingsley LA, Groner G, et al. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 2004, 18:793-798.
38. Morris A, Sciurba FC, Lebedeva IP, et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004, 170:408-413.
39. Totet A, Latouche S, Lacube P, et al. Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg Infect Dis 2004, 10:667-673.
40. Medrano FJ, Montes-Cano M, Conde M, et al. Pneumocystis jirovecii in general population. Emerg Infect Dis 2005, 11:245-250.